Reply to: "The role of NAFLD in extrahepatic malignancies: The importance of ruling out the effect of obesity"

Affiliations

¹ Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
² Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: hch@amc.seoul.kr.
³ Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

Comment

Gi-Ae Kim et al. J Hepatol. 2018 May.

. 2018 May;68(5):1094-1095.

doi: 10.1016/j.jhep.2018.01.007. Epub 2018 Feb 13.

¹ Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
² Department of Gastroenterology, Asan Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address: hch@amc.seoul.kr.
³ Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

No abstract available

Comment on

Association between non-alcoholic fatty liver disease and cancer incidence rate.
Kim GA, Lee HC, Choe J, Kim MJ, Lee MJ, Chang HS, Bae IY, Kim HK, An J, Shim JH, Kim KM, Lim YS. Kim GA, et al. J Hepatol. 2017 Nov 2:S0168-8278(17)32294-8. doi: 10.1016/j.jhep.2017.09.012. Online ahead of print. J Hepatol. 2017. PMID: 29150142
The role of NAFLD in extrahepatic malignancies: The importance of ruling out the effect of obesity.
Zheng B, Zhu YJ, Wang HY, Chen L. Zheng B, et al. J Hepatol. 2018 May;68(5):1093-1094. doi: 10.1016/j.jhep.2017.12.030. Epub 2018 Jan 31. J Hepatol. 2018. PMID: 29360552 No abstract available.